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An antiserum raised against an EPKC-specific peptide recognizes EPKC with an apparent molecular weight of 97 kDa in cytosol of mouse brain. 
No cross-reaction with c@,yPKC or the GPKC-like p76-kinase is observed. EPKC is mainly present in brain. Just traces of this PKC isoenzyme 
can be detected in some other murine tissues. Ontogenetic studies indicate that the amount of EPKC in murine brain increases constantly and reaches 
a maximal level at day 7 after bir:h, Upon TPA activation EPKC is translocated from the cytosol to the particulate frastion in a brain homogenate. 
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1, INTRODUCTION 
Many proteins involved in signal transduction belong 
to families of closely related enzymes. Each individual 
protein within such a family might be involved in a 
specific pathway. 
Protein kinase C (PKC), one of the key enzymes of 
phospholipase-C-mediated signal transduction, also 
consists of a family of several related enzymes [l]. No- 
lecular cloning analysis has revealed that the PKC fam- 
ily can be subdivided into two major groups. Conven- 
tional a@ and yPKC contain a putative Ca-binding 
domain C2 [l], whereas J,E and PKC are lacking this 
domain [2,3]. The latter finding was in accord with our 
earlier report on a Ca2+ -unresponsive PKC-like kinase 
in murine epidermis and spleen [4,5]. Recently, we were 
abie to purifjr this kinase from porcine spleen. The novel 
enzyme does indeed not respond to Ca2+ and appears 
to be a PKC of the &type [6,9]. Very recently, the cDNA 
of vPKC, a new member of the Ca”-independent sub- 
group of the PKC family, was cloned and sequenced [S]. 
The novel enzyme exhibits an about 60% sequence h.o- 
mology to EPKC. Another PKC cDNA (PKC-L) de- 
scribed by Bather et al. [9] appears to be identical with 
vPKC. EPKC was expressed in transfected COS cells 
[2,3] as well as in transfected insect cells [lo] and was 
purified from these cells. EPKC mRNA was found to be 
expressed predominantly in brain [2,1]. 
I-Iere we show by means of an .sPKC-specific antise- 
rum that murine EPKC is present above all in brain, and 
there mainly in the cytosol, and that the enzyme is trans- 
located from the cytosol to the particulate fraction upon 
TPA activation. 
2. MATERIALS AND METHODS 
2.1. Materials 
12-O-Tetradecanoylphorbol-13-acetate (TPA), Freund’s adjuvans 
(Sigma, Munich, Germany); the oligopeptide DEAIVKQINQEEFK 
was synthesized by Novabiochem (Laufingen, Switzerland). 
2.2. Antiserum 
An antiserum was raised against the oligopeptide DEAIVKQIN- 
QEEFK in rabbits. The amino acid sequence of the oligopeptide 
corresponded to the sequence 712-725 of&PKC [2,3]. The oligopeptide 
was coupled to thyroglobulin using carbodiimide as described by Har- 
low and Lane [12]. Female rabbits (Chincilla-Bastard, 2.5-3 kg) were 
used for immunization as described previously [7]. 
2.3. Preparation of cytosol from various murine tissues 
Female NMRI mice (age 7-8 weeks) were used in all experiments. 
After sacrifice of the animals, tissues were dissected, immediately 
frozen in liquid nitrogen and stored at -7OOC. The tissues were homo- 
genized in Tris-EDTA buffer (SO mM Tris, pH 7.5, 1 mM EDTA) and 
the homogenate was centrifuged at 100 000 x g for 30 min. The 
supernatant was termed cytosol. 
Abbreviations: PKC, protein kinase C; TPA, 12-O-tetradecanoylphor- 
bol-13-acetate; SDS-PAGE, SDS-polyacrylamide gel electrophoresis; 
ELISA, enzyme-linked immunosorbent assay. 
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2.4. Translocalion of &PKC in a mouse brain homogenate 
One mouse brain was homogenized in 4 ml Tris-EDTA buffer with 
an Ultraturax homogenizer. 2 ml each of the homogenate were incuba- 
ted with 20 ~1 of acetone and 20 @l of 100 ,uM TPA in acetone, 
respectively, at 0-2°C for 10 min. Then the homogenate was separated 
by centrifugation at 100 000 X g for 30 min into cytosol and particulate 
fraction. The particulate fraction was extracted with 2 ml of sample 
buffer (10 mM NaKHPOI, pH 7.2, 5% SDS, 10%/&mercaptoethanol, 
115 
10% glycerol) and both the cytosol and the particulate extract were 
applied to SDS-polyacrylamide gel clectrophoresis (SDS-PAGE). 
The following procedures were performed as described previously: 
purification of a@,yPKC from mouse brain [§I, purification of p76- 
kinase (&type PKC) from porcine spleen [7], enzyme-linked immuno- 
sorbent assay (ELISA) [7], immunoblot [5], phosphorylation of cy 
tosol proteins [I, SDS-PAGE [13], determination of protein 1141. 
3. RESULTS AND DISCUSSION 
EPKC belongs to a recently discovered subgroup of 
related PKC isoenzymes designated &E,C [2,3] and 17 [S]. 
Recently, we described the purification and characteri- 
zation of a S-type PKC from porcine spleen (p76-kinase; 
[7]). This was the first enzyme of these PKC subspecies 
purified to homogeneity from a tissue. The &type PKC 
was found to be almost ubiquitous in different species 
and murine tissues [15]. Particularly high concentra- 
tions were observed in epithelial tissues, such as epider- 
mis. The enzyme was barely detectable in the cytosol 
but appeared to be restricted to the particulate fraction. 
The aim of this study was to compare the EPKC with 
the J-type PMC regarding tissue distribution and cellu- 
lar localization. For this purpose an antiserum was 
raised in rabbits against a synthetic peptide with a se- 
quence corresponding to the COOL-l-terminal residues 
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Fig. I. Enzyme-linked immunosorbent assay (ELISA) of the antise- 
rum raised against a peptide of &PKC. The ELISA was performed as 
described previously [7]. Purified PKC (type ~a@,~) from mouse brain 
(left, 0.15 ,~cg protein/well), purified S-type PKC from porcine spleen 
(center, 0.15 ,ug protein/well) and the speptide (right, 6.25 &well) 
were used to coat the microtiter plates. Pre-immune serum (preserum) 
served as a control. 
712-725 of EPKC (Epeptide). The specificity of the anti- 
Epeptide antiserum is demonstrated in Figs. 1 and 2A. 
In an enzyme-linked immunosorbent assay (ELBA) the 
anti-gpeptide antiserum reacts in a dose-dependent 
manner with the Epeptide, but not with o$,yPKC from 
TPA - + -I- 
Cytosol Particulate 
Fig. 2. Immunoblots with the &-peotide anric~r~rr.. -1. na . ..r.;ia; bl& uyrusoi, punned a@,yPKC from mouse brain and purified &type PKC from 
porcine spleen. B, Cytosols of various murine tissues. C. Cytosol and particulate fraction of a mouse brain homogenate after incubation with or 
without I ,uM TPA at O-2% for 10 min (see section 2) Cytosols and particulate fractions (100 fig protein each) as well as the purified enzymes 
(0.15 pg protein each) were applied to SDS-PAGE and the immunoblots were performed as described in section 2. Molecular masses were 
determined from standard proteins: myosin (205 kDa), @galactosidase (116 kDa), phosphorylase b (97 kDa), bovine serum albumin (68 kDa), 
ovalbwmin (43 kDa), and carbonic anhydrase (29 kDa). 
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Fig. 3. Ontogeny of the BPKC in mouse brain. Brain was taken from 
mice on various days after birth (see abscissa). Cytosols (100 1(g of 
protein) were applied to SDS-PAGE and immunoblots were perform- 
ed using the anti-Epeptide antiserum and an %-labelled anti-rabbit- 
IgG instead of the peroxidase-conjugated antibody, as described in 
section 2. The autoradiograms of the immunoblots were quantitated 
by densitometry. 
mouse brain or the SPKC-like p76-kinase from porcine 
spleen (Fig. 1). The pre-immune serum does not react 
with any of the presented antigens (e$,yPKC; p76- 
kinase, Epeptide). Immunoblots of murine brain eytosol 
using this antiserum showed a protein doublet around 
97 kDa, co-migrating with the marker protein phospho- 
rylnse b (Fig. 2A). The immunostained doublet appears 
to be characteristic for EPKC, as reported previously by 
Strulovici et al. [16]. The evidently higher molecular 
weight of EPKC as compared to the other PKC isoen- 
zymes (around 80 kBa or lower) facilitates an unequiv- 
ocal identification of the immunostained band with 
EPKC. IJpon immunoblotting neither a,j?,yPKC nor 
the GPKC-like p76-kinase are recognized by the anti- 
serum. After phosphorylation of brain cytosol proteins 
with [Y-~~P]ATP in the presence of phosphatidyl serine 
and TPA, the 97-kDa-protein is iabeiiuci, indicating an 
autophosphorylation of EPKC (data not shown). 
When we examined the cytosol (100 pg of protein) of 
several murine tissues, sPKC was found to be present 
predominantly in brain (Fig. 2B). This is in agreement 
with the almost exclusive expression of rnRNA for 
EPKC in brain [2,&l 1 J. Traces of EPKC can be detected 
in lung and pancreas, especially when freshly prepared 
total tissue extracts are examined (data not shown). 
Other tissues, such as spleen, epidermis and thymus 
(‘l-day-old mice) do not contain sPKC in amounts de- 
monstrable by this method (Fig. 2B). EPKC can still be 
detected by immunoblotting in a IO-fold diluted brain 
cytosol (10 lug of protein; data not shown). Brain of 
newborn mice also contains EPKC. The enzyme concen- 
tration increases after birth and reaches a maximal level 
at around day 7 after birth (Fig. 3). Conversely, the 
amount of the &type PKC in mouse brain [15] and 
similarly of yPKC in rat brain [17] does not change 
significantly up to day 7 after birth and then increases 
dramatically. After treatment of a mouse brain homo- 
genate with 1 ,uM TPA at O-ZC for 10 min with subse- 
quent separation of the homogenate into a cytosolic and 
a particulate fraction, the concentration of EPKC is 
reduced in the cytosol and increases in the partisulate 
fraction (Fig. 2C). While in the cytosol two protein 
bands are immunostained in the 97 kBa range (dou- 
blet), apparently only the lower band becomes visible in 
the particulate fraction after irnmunostaining. In un- 
treated samples EPKC is located predominantly in the 
cytosol. This is in contrast to the &type PMC 17,151 
which is located almost exclusively in the particulate 
fraction. Our observation of the TPA-induced in vitro 
translooation of &PKC is in agreement with data of 
Akita et al. [l S] on the phorbol ester-induced transloca- 
tion of sPKC in transfeoted COS sells and of Kiley et 
al. [19] on the phorbol ester-induced translocation of 
EPKC in rat pituitary cells. On the other hand, Wei- 
denreich et al. [20] were unable to show translocation 
of &PKC upon treatment of cultured neurons with TPA 
or insulin. 
Taken together, 6 and EPKC, both Ca*+-unrespon- 
sive subspecies of the PKC family, differ significantly 
with respect to their murine tissue distribution, cellular 
localization and ontogeny. The special roles of these 
isoenzymes in the various tissues and cell compartments 
remain to be elucidated. Since PKC is thought to play 
an essential role in the phorbol ester-induced tumor 
promotion in mouse skin, it is intriguing that concern- 
ing the Ca*“-unresponsive PKC subspecies mouse epi- 
dermis lacks EPKC and instead contains the SPKC-like 
p&2-kinase which resembles the p-76-kinase of porcine 
spleen [7,15]. 
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